| RS1213146356 |
CHD8
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with autism and macrocephaly, Intellectual developmental disorder with autism and macrocephaly |
| RS1213152015 |
COCH
|
Health Risk |
Pathogenic |
Bilateral sensorineural hearing impairment, Bilateral sensorineural hearing impairment |
| RS1213164662 |
CC2D2A
|
Health Risk |
Likely pathogenic |
COACH syndrome 2, Meckel syndrome |
| RS1213175712 |
ALS2
|
Health Risk |
Likely pathogenic |
Infantile-onset ascending hereditary spastic paralysis, Infantile-onset ascending hereditary spastic paralysis |
| RS12131800 |
CACNA1E
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1213180923 |
ZBTB24
|
Health Risk |
Pathogenic |
Immunodeficiency-centromeric instability-facial anomalies syndrome 2, Immunodeficiency-centromeric instability-facial anomalies syndrome 2 |
| RS1213185511 |
ADCY5
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1213187506 |
SFTPB
|
Health Risk |
Likely pathogenic |
SFTPB-related disorder, SFTPB-related disorder |
| RS1213194580 |
GDF1
|
Health Risk |
Pathogenic |
— |
| RS1213203489 |
SACS
|
Health Risk |
Pathogenic |
Spastic paraplegia, Charlevoix-Saguenay spastic ataxia |
| RS1213228037 |
CNOT3
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with speech delay, autism |
| RS1213240312 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Inborn genetic diseases |
| RS1213244424 |
NOTCH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS1213252028 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS1213265293 |
CNGB1
|
Health Risk |
Likely pathogenic |
— |
| RS1213271945 |
WDR62
|
Health Risk |
Likely pathogenic |
— |
| RS1213272601 |
XRCC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1213277033 |
COL4A4
|
Health Risk |
Likely pathogenic |
Autosomal recessive Alport syndrome, Autosomal recessive Alport syndrome |
| RS1213277062 |
PTS
|
Health Risk |
Pathogenic |
6-Pyruvoyl-tetrahydrobiopterin synthase deficiency, 6-Pyruvoyl-tetrahydrobiopterin synthase deficiency |
| RS1213277350 |
BRCA2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary breast ovarian cancer syndrome |
| RS1213279792 |
ALMS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Alstrom syndrome, Cardiovascular phenotype |
| RS1213285317 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1O, Cardiovascular phenotype |
| RS1213286417 |
CEP290
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Meckel-Gruber syndrome |
| RS1213326298 |
AIRE
|
Health Risk |
Pathogenic |
Polyglandular autoimmune syndrome, type 1 |
| RS1213338072 |
DST
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary sensory and autonomic neuropathy type 6, Epidermolysis bullosa simplex 3 |
| RS1213350464 |
FANCM
|
Health Risk |
Likely pathogenic |
FANCM-related disorder, FANCM-related disorder |
| RS1213368057 |
RELA
|
Health Risk |
Pathogenic |
— |
| RS1213371362 |
ERCC6
|
Health Risk |
Pathogenic/Likely pathogenic |
Cerebrooculofacioskeletal syndrome 1, Cerebrooculofacioskeletal syndrome 1 |
| RS1213371923 |
MYO15A
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive nonsyndromic hearing loss 3, Autosomal recessive nonsyndromic hearing loss 3 |
| RS1213378896 |
ASS1
|
Health Risk |
Likely pathogenic |
Citrullinemia type I, Citrullinemia type I |
| RS1213412404 |
SLC7A9
|
Health Risk |
Likely pathogenic |
— |
| RS1213421499 |
CACNA1S
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS1213427451 |
COL1A1
|
Health Risk |
Pathogenic |
Osteogenesis imperfecta type I, Ehlers-Danlos syndrome |
| RS1213452826 |
LOX
|
Health Risk |
Pathogenic/Likely pathogenic |
Aortic aneurysm, familial thoracic 10 |
| RS1213456960 |
IFT172
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 71, Short-rib thoracic dysplasia 10 with or without polydactyly |
| RS1213469406 |
KIT
|
Health Risk |
Conflicting classifications of pathogenicity |
Gastrointestinal stromal tumor, Hereditary cancer-predisposing syndrome |
| RS1213473194 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Hereditary cancer-predisposing syndrome |
| RS1213475397 |
MED12
|
Health Risk |
Conflicting classifications of pathogenicity |
FG syndrome, MED12-related disorder |
| RS1213481140 |
ATP7B
|
Health Risk |
Pathogenic |
Wilson disease, Wilson disease |
| RS1213484295 |
SATB1
|
Health Risk |
Likely pathogenic |
Kohlschutter-Tonz syndrome-like, Kohlschutter-Tonz syndrome-like |
| RS1213514224 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1213550131 |
LARS2
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1213557289 |
DNAAF2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia |
| RS1213569173 |
COL17A1
|
Health Risk |
Pathogenic |
— |
| RS1213596075 |
BCKDHA
|
Health Risk |
Likely pathogenic |
Maple syrup urine disease, Maple syrup urine disease |
| RS1213600316 |
EPG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Vici syndrome, Inborn genetic diseases |
| RS1213619304 |
TYMP
|
Health Risk |
Likely pathogenic |
Mitochondrial DNA depletion syndrome 1, Mitochondrial DNA depletion syndrome 1 |
| RS1213637962 |
COL4A3
|
Health Risk |
Likely pathogenic |
— |
| RS1213672903 |
COL27A1
|
Health Risk |
Pathogenic |
— |
| RS1213680890 |
CORO1A
|
Health Risk |
Pathogenic |
Severe combined immunodeficiency due to CORO1A deficiency, Severe combined immunodeficiency due to CORO1A deficiency |
| RS1213702908 |
CBLIF
|
Health Risk |
Likely pathogenic |
Hereditary intrinsic factor deficiency, Hereditary intrinsic factor deficiency |
| RS1213710245 |
WDR62
|
Health Risk |
Pathogenic |
Microcephaly 2, primary |
| RS1213724402 |
TBCK
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypotonia, infantile |
| RS1213743769 |
KCNH2
|
Health Risk |
Pathogenic |
Long QT syndrome, Long QT syndrome |
| RS1213746899 |
GJB1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth Neuropathy X, Charcot-Marie-Tooth Neuropathy X |
| RS1213752306 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |
| RS1213755599 |
TECPR2
|
Health Risk |
Pathogenic |
Hereditary spastic paraplegia 49, Hereditary spastic paraplegia 49 |
| RS1213764655 |
KCNJ1
|
Health Risk |
Likely pathogenic |
Bartter disease type 2, Bartter disease type 2 |
| RS1213787718 |
KAT6B
|
Health Risk |
Conflicting classifications of pathogenicity |
Genitopatellar syndrome, Genitopatellar syndrome |
| RS1213808242 |
TBX4
|
Health Risk |
Pathogenic |
— |
| RS1213826124 |
KCNH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Long QT syndrome |
| RS1213827359 |
ACADM
|
Health Risk |
Likely pathogenic |
Medium-chain acyl-coenzyme A dehydrogenase deficiency, Medium-chain acyl-coenzyme A dehydrogenase deficiency |
| RS1213841516 |
SMAD6
|
Health Risk |
Conflicting classifications of pathogenicity |
Radioulnar synostosis, Frontal bossing |
| RS1213865421 |
SMARCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Rhabdoid tumor predisposition syndrome 2, Rhabdoid tumor predisposition syndrome 2 |
| RS1213870507 |
NBN
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Microcephaly |
| RS1213870519 |
CD3E
|
Health Risk |
Pathogenic |
Immunodeficiency 18, Immunodeficiency 18 |
| RS1213891703 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS1213894295 |
BARD1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1213908678 |
CALM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 4, Long QT syndrome 14 |
| RS1213914911 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal dominant 2 |
| RS1213915943 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms |
| RS1213927843 |
LTBP4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cutis laxa with severe pulmonary, gastrointestinal and urinary anomalies |
| RS1213930919 |
TTN
|
Health Risk |
Likely pathogenic |
Hypertrophic cardiomyopathy 9, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS1213961819 |
NAGLU
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2V, Mucopolysaccharidosis |
| RS1213965862 |
DYSF
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2B, Neuromuscular disease caused by qualitative or quantitative defects of dysferlin |
| RS1213970824 |
POLD1
|
Health Risk |
Conflicting classifications of pathogenicity |
Colorectal cancer, susceptibility to |
| RS1213976958 |
PLOD3
|
Health Risk |
Pathogenic |
— |
| RS1214001883 |
TULP1
|
Health Risk |
Pathogenic |
— |
| RS1214012000 |
RPGRIP1L
|
Health Risk |
Pathogenic/Likely pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1214047183 |
GFM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1, Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 |
| RS1214070111 |
FGA
|
Health Risk |
Pathogenic |
Hypofibrinogenemia, Hypofibrinogenemia |
| RS1214096526 |
RYR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Malignant hyperthermia, susceptibility to |
| RS1214104267 |
PIGO
|
Health Risk |
Likely pathogenic |
Hyperphosphatasia with intellectual disability syndrome 2, Hyperphosphatasia with intellectual disability syndrome 2 |
| RS1214130226 |
DLD
|
Health Risk |
Pathogenic |
Pyruvate dehydrogenase E3 deficiency, Pyruvate dehydrogenase E3 deficiency |
| RS1214154774 |
BLM
|
Health Risk |
Likely pathogenic |
Bloom syndrome, Hereditary cancer-predisposing syndrome |
| RS1214177178 |
ELAC2
|
Health Risk |
Likely pathogenic |
ELAC2-related disorder, ELAC2-related disorder |
| RS1214197748 |
COPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Autoimmune interstitial lung disease-arthritis syndrome, COPA-related disorder |
| RS1214213337 |
CHEK2
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS1214222702 |
ACADVL
|
Health Risk |
Likely pathogenic |
Very long chain acyl-CoA dehydrogenase deficiency, Very long chain acyl-CoA dehydrogenase deficiency |
| RS1214223476 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Cardiovascular phenotype, Cardiomyopathy |
| RS1214230970 |
DNHD1
|
Health Risk |
Pathogenic |
— |
| RS1214257415 |
KIF11
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1214280939 |
PLAA
|
Health Risk |
Pathogenic |
— |
| RS1214281478 |
ALPK3
|
Health Risk |
Likely pathogenic |
— |
| RS1214305423 |
VHL
|
Health Risk |
Pathogenic |
Von Hippel-Lindau syndrome, Chuvash polycythemia |
| RS1214305633 |
DPYD
|
Health Risk |
Likely pathogenic |
Dihydropyrimidine dehydrogenase deficiency, Dihydropyrimidine dehydrogenase deficiency |
| RS121434215 |
ARSA
|
Health Risk |
Pathogenic |
Metachromatic leukodystrophy, adult type |
| RS121434216 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia - telangiectasia variant, Ataxia-telangiectasia syndrome |
| RS121434218 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia without immunodeficiency, Ataxia-telangiectasia without immunodeficiency |
| RS121434219 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia without immunodeficiency, Ataxia-telangiectasia syndrome |